Elementis (LON:ELM)‘s stock had its “buy” rating restated by research analysts at UBS Group in a report issued on Wednesday, ThisIsMoney.Co.Uk reports. They currently have a GBX 165 ($2.17) price target on the stock, down from their prior price target of GBX 175 ($2.30). UBS Group’s price target suggests a potential upside of 22.22% from the stock’s previous close.
A number of other equities analysts have also commented on the stock. JPMorgan Chase & Co. lowered their price target on shares of Elementis from GBX 195 ($2.57) to GBX 170 ($2.24) and set an “overweight” rating on the stock in a research report on Wednesday, January 15th. Jefferies Financial Group cut their price objective on shares of Elementis from GBX 190 ($2.50) to GBX 153 ($2.01) and set a “hold” rating for the company in a report on Tuesday. Finally, Berenberg Bank restated a “buy” rating on shares of Elementis in a research report on Tuesday, January 14th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Elementis has an average rating of “Buy” and an average target price of GBX 183.83 ($2.42).
Shares of Elementis stock opened at GBX 135 ($1.78) on Wednesday. The firm has a 50-day moving average of GBX 168 and a 200-day moving average of GBX 154.05. The stock has a market cap of $783.70 million and a PE ratio of 15.52. Elementis has a 52-week low of GBX 127.30 ($1.67) and a 52-week high of GBX 198.90 ($2.62). The company has a debt-to-equity ratio of 70.37, a quick ratio of 1.37 and a current ratio of 2.37.
Elementis plc manufactures and sells specialty chemicals in North and South America, Europe, and Asia. It operates through Specialty Products and Chromium segments. The Specialty Products segment offers functional additives to the personal care, coatings, and energy end markets, as well as oilfield and construction sectors.
Featured Story: Balanced Fund
Receive News & Ratings for Elementis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elementis and related companies with MarketBeat.com's FREE daily email newsletter.